# Digital Measurement of Subjective Experiences in Alzheimer Disease and Related Dementias (AD/ADRD)

**Authors:** Colin Depp, Jason Holden, Eric Granholm

PMC · DOI: 10.2196/71920 · JMIR Aging · 2025-11-18

## TL;DR

This paper explores using passive sensing technologies to measure subjective experiences in Alzheimer's and related dementias, aiming to improve care and reduce caregiver burden.

## Contribution

The paper identifies key challenges in translating passive sensing into practical tools for measuring subjective experiences in AD/ADRD.

## Key findings

- Passive sensing shows potential for quantifying subjective experiences in AD/ADRD.
- Technical and ethical challenges hinder the translation of passive sensing into clinical applications.
- Addressing these challenges could improve monitoring and treatment of behavioral symptoms in AD/ADRD.

## Abstract

Symptoms such as loss of pleasure, agitation, and sadness are subjective experiences that contribute significantly to caregiver burden and health care costs in Alzheimer disease and related dementias (AD/ADRD). However, traditional self-report measures of subjective experiences are limited in AD/ADRD due to cognitive impairments and awareness. Passive sensing, which collects data without active participant input, has emerged as a promising approach to quantify aspects of subjective experiences. Smartphones, wearables, and in-home sensors can quantify mobility, physiology, speech, and social interaction markers of constructs relevant to AD/ADRD. Available research indicates potential but is largely at the proof-of-concept stage. In this Commentary, we discuss several roadblocks to future translation of passive sensing in measuring subjective experiences in AD/ADRD, including technical implementation, data harmonization, validation, ethical and privacy principles. Addressing these challenges could lead to transformative applications to care for AD/ADRD, enabling precise monitoring of behavioral symptoms and related treatment targets, ultimately improving quality of life for persons with AD/ADRD and their caregivers.

## Linked entities

- **Diseases:** Alzheimer disease (MONDO:0004975)

## Full-text entities

- **Diseases:** Dementias (MESH:D003704), agitation (MESH:D011595), loss (MESH:D016388), AD (MESH:D000544), cognitive impairments (MESH:D003072)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12626243/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12626243/full.md

---
Source: https://tomesphere.com/paper/PMC12626243